Finland· FI-REL-REL695

Paraflex Comp

A chlorzoxazon, kombinationen, exkl. psycholeptika product containing chlorzoxazone + dextropropoxyphene napsilate + acetylsalicylic acid, registered in Finland by AstraZeneca Oy. The same ATC class is registered in 2 of our 19 countries.

ATC M03BB53

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedParaflex CompATCM03BB53REGISTER NO.FI-REL-REL695PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Chlorzoxazon, kombinationen, exkl. psycholeptika is registered in 2 of 19 countries.

Countries holding a registration under ATC M03BB53 (chlorzoxazon, kombinationen, exkl. psycholeptika), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Chlorzoxazon, kombinationen, exkl. psycholeptika · ATC M03BB53

2 / 19 countries

  • Canada
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Chlorzoxazone + Dextropropoxyphene napsilate + Acetylsalicylic acid
Manufacturer
AstraZeneca Oy
Country
Finland (FI)
ATC code
M03BB53
ATC class
Chlorzoxazon, Kombinationen, exkl. Psycholeptika
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under M03BB53

Chlorzoxazon, kombinationen, exkl. psycholeptika, as other registers publish it.

All chlorzoxazon, kombinationen, exkl. psycholeptika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c19f8c12-b7a1-4f90-a1ad-df3562062a3e
GET /v1/drugs/c19f8c12-b7a1-4f90-a1ad-df3562062a3e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "4",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "ED",
  "strength": null,
  "atc_label": "klooritsoksatsoni, yhdistelmävalmisteet",
  "ma_number": "5731",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL695",
  "authorised_at": "1969-04-16"
}

See everything about chlorzoxazon, kombinationen, exkl. psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.